- Type / Class
- Equity / Common Stock
- Shares outstanding
- 61,152,075
- Total 13F shares
- 13,995,656
- Share change
- +119,062
- Total reported value
- $281,311,000
- Price per share
- $20.10
- Number of holders
- 22
- Value change
- +$4,791,129
- Number of buys
- 7
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04351P101:
Top shareholders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5.6%
|
3,412,857
|
$45,289,000 | — | 30 Jun 2016 | |
| FMR LLC |
13F
|
Company |
4.1%
|
2,512,824
|
$33,345,000 | — | 30 Jun 2016 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.6%
|
2,191,000
|
$29,075,000 | — | 30 Jun 2016 | |
| Vivo Capital, LLC |
13F
|
Company |
2.9%
|
1,766,832
|
$23,446,000 | — | 30 Jun 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.2%
|
745,521
|
$9,893,000 | — | 30 Jun 2016 | |
| VHCP Management II, LLC |
13F
|
Company |
1.2%
|
721,152
|
$9,570,000 | — | 30 Jun 2016 | |
| JANUS HENDERSON INVESTORS US LLC |
13F
|
Company |
1.1%
|
662,894
|
$8,797,000 | — | 30 Jun 2016 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.77%
|
472,800
|
$6,274,000 | — | 30 Jun 2016 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.49%
|
300,000
|
$3,981,000 | — | 30 Jun 2016 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.43%
|
261,800
|
$3,474,000 | — | 30 Jun 2016 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.33%
|
202,520
|
$2,687,000 | — | 30 Jun 2016 | |
| Sculptor Capital LP |
13F
|
Company |
0.25%
|
149,900
|
$1,990,000 | — | 30 Jun 2016 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.16%
|
100,000
|
$1,327,000 | — | 30 Jun 2016 | |
| VHCP Management, LLC |
13F
|
Company |
0.15%
|
90,000
|
$1,194,000 | — | 30 Jun 2016 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.13%
|
76,511
|
$1,015,000 | — | 30 Jun 2016 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.1%
|
62,254
|
$826,000 | — | 30 Jun 2016 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.09%
|
53,241
|
$707,000 | — | 30 Jun 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.08%
|
51,256
|
$680,000 | — | 30 Jun 2016 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.03%
|
16,000
|
$212,000 | — | 30 Jun 2016 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.02%
|
13,100
|
$174,000 | — | 30 Jun 2016 | |
| Quantitative Systematic Strategies LLC |
13F
|
Company |
0.02%
|
11,925
|
$162,000 | — | 30 Jun 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,599
|
$21,000 | — | 30 Jun 2016 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
608
|
$8,000 | — | 30 Jun 2016 |
Institutional Holders of Ascendis Pharma A/S - Common Stock (ASND) as of Q3 2016
As of 30 Sep 2016,
Ascendis Pharma A/S - Common Stock (ASND) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,995,656 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, FMR LLC, ORBIMED ADVISORS LLC, Vivo Capital, LLC, BAKER BROS. ADVISORS LP, VHCP Management II, LLC, JANUS CAPITAL MANAGEMENT LLC, ACUTA CAPITAL PARTNERS, LLC, Rock Springs Capital Management LP, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
22
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2016 vs Q2 2016 Across Filers
Q2 2016 holders
23
Q3 2016 holders
22
Holder diff
-1
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 Value $ | Q3 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.